SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001325447-13-000043
Filing Date
2013-06-07
Accepted
2013-06-07 14:34:51
Documents
1

Document Format Files

Seq Description Document Type Size
1 ttp05311313ga.txt SC 13G/A 6239
  Complete submission text file 0001325447-13-000043.txt   7891
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 4152444990
TITAN PHARMACEUTICALS INC (Subject) CIK: 0000910267 (see all company filings)

IRS No.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-46083 | Film No.: 13900275
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 1345 AVENUE OF THE AMERICAS NEW YORK NY 10105
Business Address 1345 AVENUE OF THE AMERICAS NEW YORK NY 10105 212-698-3363
First Eagle Investment Management, LLC (Filed by) CIK: 0001325447 (see all company filings)

IRS No.: 571156902 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A